NEWS
- 2024.12.12 EPS Group Presented as 9th International Conference on Vaccines Research & Development
- 2024.08.09 EPS Group Notice on Reorganization
- 2024.05.09 News EPS Holdings, Suzuken Group, and Bushu Pharmaceuticals Sign Partnership Agreement to Support the Introduction of Unapproved Drugs (Drug Loss Products) into the Japanese Market
- 2024.04.23 News IRO Business Providing Total Business Solutions Starts on Full Scale
-Elimination of drug lag and drug loss, and support for foreign biotech companies entering the Japanese market- - 2024.03.21 EPS Group EPNextS Group will collaborate with Frontage Laboratories, Inc. for Early Phase Clinical Trial and Clinical Site Management in the United States to Improve “Drug Lag” and “Drug Loss” Issues in Japan.
EPS Group supports the health industry now and in the future
EPS continues to support people's health with highly specialized and diverse services.
EPS Group supports the health industry now and in the future
EPS continues to support people's health with highly specialized and diverse services.
